NEWS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
4th Annual Evercore ISI HeathCONx Conference – Presentation
Webcast, Nov 30, 2021 at 10:05am EST Download Presentation, Click Here
Piper Sandler 33rd Annual Healthcare Conference – Presentation
Webcast, Nov 22, 2021 at 10:00am EST Download Presentation, Click here
Sutro Biopharma to Participate in Two Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
Jefferies London Healthcare Conference – Presentation
Webcast: Nov 18, 2021 at 3:00am EST Download: Click Here
Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors
- Heidi Hunter, accomplished healthcare leader and President of Cardinal Health Specialty Solutions, to bring additional global biopharma strategic and operational expertise to Sutro's Board - SOUTH SAN FRANCISCO, Nov. 17,2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a...
Stifel 2021 Virtual Healthcare Conference – Presentation
Webcast: Nov 15, 2021 at 1:20pm EST Download: Click Here
Credit Suisse 30th Annual Healthcare Conference – Presentation
Webcast, Nov 10, 2021 at 4:20pm EST Download Presentation, Click Here
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
- Patient enrollment has been completed for the STRO-002 Phase 1 ovarian cancer dose-expansion cohort, and an interim data update is expected in the second half of 2021 – - STRO-001 Phase 1 dose escalation for non-Hodgkin’s lymphoma and multiple myeloma is ongoing to...
Sutro Biopharma to Participate in Three Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China
SOUTH SAN FRANCISCO and SHANGHAI, China, Oct. 12, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create...